CDKN2A and neoplasm: The effects of the SNHG26‐CDKN2A axis on Cu + ELES(copper plus elesclomol)‐induced cuproptosis and CD8+ T cell‐mediated anti‐tumour immunity were evaluated through cell viability, apoptosis, co‐culture cytotoxicity and migration assays.